Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$43.89
-1.1%
$36.78
$26.56
$52.41
$1.26B0.8476,226 shs278,359 shs
Paragon 28, Inc. stock logo
FNA
Paragon 28
$13.11
+0.1%
$13.11
$4.65
$13.13
$1.10B1.471.16 million shs19.38 million shs
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
$6.29
+0.9%
$6.50
$5.47
$10.14
$936.43M1.76675,108 shs319,320 shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$10.24
+2.3%
$9.06
$8.15
$22.40
$285.43M2.07191,816 shs73,397 shs
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
0.00%+7.23%+15.44%+35.88%+0.37%
Paragon 28, Inc. stock logo
FNA
Paragon 28
0.00%0.00%0.00%+0.38%+101.00%
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
0.00%+5.81%-0.87%-10.98%-7.84%
ZimVie Inc. stock logo
ZIMV
ZimVie
0.00%+10.58%+12.28%+8.13%-44.83%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
1.2347 of 5 stars
2.41.00.00.01.32.50.6
Paragon 28, Inc. stock logo
FNA
Paragon 28
0.5399 of 5 stars
1.10.00.00.01.42.50.6
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
3.4457 of 5 stars
3.53.00.00.00.63.31.9
ZimVie Inc. stock logo
ZIMV
ZimVie
1.927 of 5 stars
3.33.00.00.00.01.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
2.80
Moderate Buy$52.4019.39% Upside
Paragon 28, Inc. stock logo
FNA
Paragon 28
2.20
Hold$12.75-2.71% Downside
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
3.00
Buy$12.5098.89% Upside
ZimVie Inc. stock logo
ZIMV
ZimVie
2.67
Moderate Buy$16.3359.51% Upside

Current Analyst Ratings Breakdown

Latest ZIMV, ESTA, MDXG, and FNA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/13/2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$48.00
5/16/2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy ➝ Buy$62.00
5/15/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$16.00 ➝ $10.00
5/14/2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$48.00
4/14/2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageHold
4/10/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$16.00
4/9/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
4/9/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
(Data available from 7/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$166.02M7.65N/AN/A$1.90 per share23.10
Paragon 28, Inc. stock logo
FNA
Paragon 28
$256.18M4.29N/AN/A$2.05 per share6.39
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
$348.88M2.66$0.33 per share19.14$1.31 per share4.80
ZimVie Inc. stock logo
ZIMV
ZimVie
$449.75M0.63$1.86 per share5.52$13.83 per share0.74
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$84.60M-$3.10N/AN/AN/A-52.34%-196.25%-26.64%8/5/2025 (Estimated)
Paragon 28, Inc. stock logo
FNA
Paragon 28
-$57.53M-$0.63N/AN/AN/A-25.31%-37.90%-18.22%N/A
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
$42.42M$0.2723.2819.64N/A11.40%22.70%16.77%7/30/2025 (Estimated)
ZimVie Inc. stock logo
ZIMV
ZimVie
-$25.83M-$0.71N/AN/A-4.40%5.53%2.84%7/31/2025 (Estimated)

Latest ZIMV, ESTA, MDXG, and FNA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/31/2025Q2 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.2285N/AN/AN/A$112.82 millionN/A
7/30/2025Q2 2025
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
$0.06N/AN/AN/A$90.79 millionN/A
5/8/2025Q1 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.21$0.27+$0.06-$0.05$113.10 million$112.00 million
5/7/2025Q1 2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$0.83-$0.70+$0.13-$0.70$41.15 million$41.38 million
4/30/2025Q1 2025
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
$0.06$0.06N/A$0.05$86.32 million$88.21 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
N/AN/AN/AN/AN/A
Paragon 28, Inc. stock logo
FNA
Paragon 28
N/AN/AN/AN/AN/A
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
N/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
5.72
3.36
2.05
Paragon 28, Inc. stock logo
FNA
Paragon 28
0.79
3.50
1.60
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
0.09
4.70
4.13
ZimVie Inc. stock logo
ZIMV
ZimVie
0.58
2.14
1.48

Institutional Ownership

CompanyInstitutional Ownership
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
72.91%
Paragon 28, Inc. stock logo
FNA
Paragon 28
63.57%
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
79.15%
ZimVie Inc. stock logo
ZIMV
ZimVie
95.63%

Insider Ownership

CompanyInsider Ownership
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
11.09%
Paragon 28, Inc. stock logo
FNA
Paragon 28
15.32%
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
1.70%
ZimVie Inc. stock logo
ZIMV
ZimVie
3.01%
CompanyEmployeesShares OutstandingFree FloatOptionable
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
1,01828.92 million25.71 millionOptionable
Paragon 28, Inc. stock logo
FNA
Paragon 28
343,00083.94 million70.89 millionOptionable
MiMedx Group, Inc stock logo
MDXG
MiMedx Group
870147.70 million145.19 millionOptionable
ZimVie Inc. stock logo
ZIMV
ZimVie
1,77027.85 million27.01 millionOptionable

Recent News About These Companies

Wall Street Zen Upgrades ZimVie (NASDAQ:ZIMV) to "Strong-Buy"
ZimVie: Screening Cheap (Rating Upgrade)
ZimVie Inc. (ZIMV) Q1 2025 Earnings Call Transcript
ZimVie Reports First Quarter 2025 Financial Results
Q1 2025 ZimVie Inc Earnings Call
ZimVie announces launch of its Immediate Molar Implant system in US
ZimVie launches molar implant system
Needham Remains a Hold on ZimVie Inc (ZIMV)
ZimVie initiated with a Buy at B. Riley

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Establishment Labs stock logo

Establishment Labs NASDAQ:ESTA

$43.89 -0.47 (-1.06%)
As of 07/3/2025 03:57 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Paragon 28 stock logo

Paragon 28 NYSE:FNA

$13.10 +0.02 (+0.11%)
Closing price 04/17/2025
Extended Trading
$13.10 0.00 (0.00%)
As of 04/17/2025 05:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.

MiMedx Group stock logo

MiMedx Group NASDAQ:MDXG

$6.28 +0.06 (+0.88%)
Closing price 07/3/2025 03:00 PM Eastern
Extended Trading
$6.16 -0.12 (-1.91%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia.

ZimVie stock logo

ZimVie NASDAQ:ZIMV

$10.24 +0.23 (+2.30%)
As of 07/3/2025 02:36 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.